Solid Biosciences Expands Team with 43,374 RSU Grants in Strategic Hiring Move - Stock Titan
2025-04-01 • Google News
Solid Biosciences LLC (SLDB)
US$ 3.3-10.08%
Price Chart
Key Statistics
Market Cap
$ 216.23M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.02M
52W High
$ 10.37
52W Low
$ 2.45
Dividend Yield
0.00%
Beta
2.33
Technicals
50-Day MA
3.8558
200-Day MA
5.4084
52 Week High
10.37
52 Week Low
2.45
About SLDB
Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States.
Employees
100
Headquarters
Charlestown, MA
CEO
Mr. Ian F. Smith A.C.A., C.P.A.
Latest News
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space - Seeking Alpha
2025-04-08 • Google News
$SLDB stock is up 11% today. Here's what we see in our data. - Nasdaq
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg